life scienc tool diagnost
idexxel road manag
high visibl earn growth ceo jon ayer cfo brian
emphas sustain growth profil support dd
growth across recur revenu stream sale innov driver
geograph expans increasingli sophist commerci effort
accompani margin expans bp annual drive dd
ep growth forese futur view maintain
estim ep move stronger
profit trajectori tp move ep
higher view greater convict lt prospect
prevent care offer increment avenu growth
clinic board us penetr adopt new prevent
care protocol pcc offer long runway growth support
durabl recur revenu stream custom alik new
data point adult canin prevent profil uncov notabl
observ call follow-on test half would
identifi without proprietari test testament commit
innov littl question sustain idxx annual price
realiz inher resili econom
environ pcc promot consist past strategi
pet-tech leader barrier entri high clear advantag
comprehens platform cohes system offer
sticki model competitor lack uniqu abil also
leverag build repositori data new product develop new
effort foster corpor account engag also increasingli
valuabl consolid us industri term zoetis/abaxi
note see somewhat less competitor market amidst like
integr disrupt catalyst earn target
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader diagnost point-of-car equip
refer laboratori servic companion anim also
provid system diagnost livestock water qualiti
share gain refer laboratori point-of-car acceler
global expans greater contribut innov new product
launch technolog advanc greater expect
growth broader anim health industri fundament
stronger expect macroeconom fx headwind
increasingli global footprint less adoption/tract futur product
launch deterior veterinari health fundament
price may rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
takeaway manag
thesi intactcompel predictability/vis earn growth manag
continu view industri fundament robust support sustain doubl digit
growth next five year estimate organ growth
highlight macro indic continu suggest posit industri trend
envis notabl headwind would derail above-market growth support
dd growth across recur revenu stream sale innov driver
cohes technolog platform geograph expans increasingli sophist
commerci strategi note reiter increment sale forc addit expect
year
term profit accompani margin expans bp annual
robust growth across profit recur revenu segment continu
refer laboratori product initi take hold also support dd ep
growth forese futur view
broadli continu view compel attract altern healthcar
invest strong recur revenu stream consist price realiz
robust custom retent healthi fundament backdrop contribut
greater predict visibl earn growth
investor day august potenti updat target innov
figur driver revenu
compani data credit suiss note us dx growth includ pet visit growth price realiz dx revenu per pet visit net
custom addit new increment revenu stream dx growth includ base market catalyst expans
benefit new increment revenu stream
prevent carelong runway growth adopt prevent care protocol
evolv client base focus well diseas prevent offer
increment avenu growth emphas build momentum
prevent care challeng pcc program total enrol reach
end repres us market penetr
new data point provid meet pcc exam adult dog
yield notabl observ call follow-on test half would
identifi without proprietari test testament innov underscor
signific valu captur veterinarian despit charg less pcc panel
note pcc price strategi consist histor promot program
pcc profil customiz urinalysi incorpor standard
pcc protocol interestingli pcc cohort alreadi includ urinalysi
posit sedivu consum util
pcc custom gener store diagnost sale growth
underscor market expans opportun pcc penetr grow emerg
challeng veterinari practic relat loss therapeut revenu altern
channel chewi com could drive greater adopt diagnost veterinarian
seek help off-set associ lost therapeut revenu consist result
survey us companion anim veterinarian see figur broadli
view diagnost revenu percentag total revenu grow today
long term
new corpor account initi new proactiv effort implement year foster
corpor account engag increasingli valuabl pe firm cs estimate
roll vet hospit us corpor chain repres vet hospit
specif invest support servic becom align
corpor practic note mike erickson former head veterinari softwar
servic spearhead idxx corpor account relationship
corpor practic often face challeng tight budget corporate-wid protocol
initi requir signific coordin howev work synergist
practic implement robust diagnost protocol grow practic revenu
enhanc connect platform also help simplifi
organ underappreci dynam emphas like multipl
competit corpor agreement come bid next year
pet-tech advantag above-market organ growth attribut part
continu innov across diagnost softwar platform specif idxx
veterinari softwar system support softwar engin
work past year improv interconnect competitor put
forth limited-to-no effort front expand repositori proprietari data
unmatch continu help acceler pace innov
competitor meaning emerg us would need develop robust
technolog build commerci sale forc educ sale forc overcom
idxx first mover data advantag
competit landscap updat zts/abax experienc meaning
chang competit landscap across refer laboratori point-of-car
market term zoeti outperform note actual see somewhat less
competitor follow juli acquisit abaxi emphas
materi particularli amidst
differ educ sale profession diagnost versu therapeut well
advantag offer comprehens innov diagnost test menu
uniqu cohes system may cumbersom unwind also high overal
diagnost revenu meaning diagnost market
penetr part depend disciplin sale forc effort
integr process sap
implement expect complet feb vs prior aug/sep
capit deploy updatestatu quo strong cash flow gener support
continu share repurchas contribut percentag point five-
year ep growth target past histori hold opportunist acquisit infrequ
small deal spend estimate million annual like target technolog
softwar tuck-in either complement veterinari suit add practic
manag capabl data asset
note step capital-expenditure year million associ two on-going
project compani expand main headquart seat though local
tax incent off-set good portion cost burden reloc core
refer lab germani nearbi locat expand capac remind idxx
new core refer lab germani track open
overlap transit period begin pressur margin
time presum reflect bp annual margin expans target howev
manag expect margin benefit new lab follow transit
pipelin ahead investor day aug manag offer increment
disclosur upcom potenti product launch howev note remain
